Literature DB >> 10942590

An integral membrane protein from the nuclear pore complex is also present in the annulate lamellae: implications for annulate lamella formation.

G Imreh1, E Hallberg.   

Abstract

Annulate lamellae (AL) are cytoplasmic arrays of stacked membrane cisternae containing densely packed pore complexes which are similar in structure to the nuclear pore complexes (NPCs) and thus referred to as annulate lamella pore complexes (ALPCs). We have recently shown that the integral nuclear pore membrane protein POM121 tagged with green fluorescent protein was correctly targeted to the nuclear pores (H. Söderqvist et al., 1997, Eur. J. Biochem. 250, 808-813). Here we have investigated if POM121 fused to three tandem molecules of yellow fluorescent protein (YFP) (POM121-YFP(3)) also was able to distribute in the extensive and well-characterized AL of RC37 and BMGE cells. Transfected RC37 or BMGE cells displayed YFP fluorescence around the nuclear envelope, as well as in the cytoplasmic AL structures. The YFP fluorescence colocalized perfectly with immunostaining using antibodies specific for different NPC proteins. The AL of both transfected and untransfected BMGE cells resisted extractions with Tx-100 and 250 mM NaCl, but were completely solubilized at 450 mM NaCl. Loss of YFP fluorescence and immunostaining for other NPC proteins correlated under all extraction conditions tested, suggesting that overexpressed POM121-YFP(3) had become an integrated part both of the NPCs and of the ALPCs. Furthermore, we have generated a stable BHK cell line expressing POM121-YFP(3) located exclusively at the nuclear pores. Treatment with vinblastine sulfate, which induces formation of AL in a variety of cells, resulted in distribution of POM121-YFP(3) into cytoplasmic foci colocalizing with immunostaining for peripheral NPC proteins. Taken together, the results show that YFP-tagged POM121 is able to distribute in drug-induced or naturally occurring AL, suggesting that POM121 is a natural constituent of ALPCs. In COS cells, which normally lack or have very little AL, YFP-tagged POM121 distributed in the nuclear pores when expressed at low levels. However, at high expression levels the YFP fluorescence also distributed in a number of brightly fluorescing cytoplasmic dots or foci, which were not present in untransfected cells. This was also true for untagged POM121. The cytoplasmic foci varied in size from 0. 1 to 2 microm and were distinctly located in the immediate vicinity of ER cisternae (without colocalizing) and also contained other nuclear pore proteins, indicating that they may represent cytoplasmic AL. This idea is supported by time-lapse studies of postmitotic assembly of these structures. This raises the question of the role of POM121 in ALPC and NPC biogenesis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942590     DOI: 10.1006/excr.2000.4935

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Cdk1 and okadaic acid-sensitive phosphatases control assembly of nuclear pore complexes in Drosophila embryos.

Authors:  Evgeny A Onischenko; Natalia V Gubanova; Elena V Kiseleva; Einar Hallberg
Journal:  Mol Biol Cell       Date:  2005-08-24       Impact factor: 4.138

2.  Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore complexes and regulate centrosome and nuclear positioning during mitotic entry.

Authors:  Daniël Splinter; Marvin E Tanenbaum; Arne Lindqvist; Dick Jaarsma; Annette Flotho; Ka Lou Yu; Ilya Grigoriev; Dieuwke Engelsma; Elize D Haasdijk; Nanda Keijzer; Jeroen Demmers; Maarten Fornerod; Frauke Melchior; Casper C Hoogenraad; René H Medema; Anna Akhmanova
Journal:  PLoS Biol       Date:  2010-04-06       Impact factor: 8.029

3.  Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.

Authors:  Natalia Garmashova; Svetlana Atasheva; Wenli Kang; Scott C Weaver; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  Pre-M phase-promoting factor associates with annulate lamellae in Xenopus oocytes and egg extracts.

Authors:  Clare Beckhelling; Patrick Chang; Sandra Chevalier; Chris Ford; Evelyn Houliston
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

5.  nup154 genetically interacts with cup and plays a cell-type-specific function during Drosophila melanogaster egg-chamber development.

Authors:  Maria R Grimaldi; Laura Cozzolino; Carla Malva; Franco Graziani; Silvia Gigliotti
Journal:  Genetics       Date:  2007-02-04       Impact factor: 4.562

6.  Nuclear pore complexes form immobile networks and have a very low turnover in live mammalian cells.

Authors:  N Daigle; J Beaudouin; L Hartnell; G Imreh; E Hallberg; J Lippincott-Schwartz; J Ellenberg
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

Review 7.  Nuclear pore complexes: dynamics in unexpected places.

Authors:  S K Lyman; L Gerace
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

8.  An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.

Authors:  Jean-Luc Senécal; Catherine Isabelle; Marvin J Fritzler; Ira N Targoff; Rose Goldstein; Michel Gagné; Jean-Pierre Raynauld; France Joyal; Yves Troyanov; Marie-Christine Dabauvalle
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

9.  Recruitment of Host Nuclear Pore Components to the Vicinity of Theileria Schizonts.

Authors:  Sandra Huber; Anina Bär; Selina Epp; Jacqueline Schmuckli-Maurer; Naja Eberhard; Bruno M Humbel; Andrew Hemphill; Kerry Woods
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

10.  Interference with the cytoplasmic tail of gp210 disrupts "close apposition" of nuclear membranes and blocks nuclear pore dilation.

Authors:  Sheona P Drummond; Katherine L Wilson
Journal:  J Cell Biol       Date:  2002-07-01       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.